ABSTRACT Platelet size, expressed as mean platelet volume, was estimated in 35 patients with chronic airflow obstruction and a wide range of arterial oxygen tension (Pao2) values. In these patients there was a negative correlation between MPV and Pao2 (r = -070). Mean platelet volume was greater (9 41 (0 86) fl) in 20 patients with an arterial Pao2 of 8 kPa (60 mm Hg) or less than in 18 normal subjects (8-21 (063) fl; p < 0001). After 24 hours of supplemental oxygen treatment there was a small fall in mean platelet volume, from 9-47 (1 06) to 8-96 (0 8) fl (p < 0 05) in 12 hypoxaemic patients (Pao2 breathing air < 8 kPa) but no change in nine non-hypoxaemic patients. Larger platelets are considered to be haemostatically more active, leading to abnormal platelet function, which may contribute to the development of pulmonary vascular damage in chronic hypoxaemia. Supplemental oxygen may partially reverse these changes by modifying platelet size and activity.
Platelets play an important part in thrombosis and vascular damage, but their role in the pulmonary vascular changes of patients with chronic hypoxic lung disease is uncertain. Pulmonary thromboembolism has frequently been found at necropsy in patients with chronic lung disease' and increased platelet activity could contribute to the thrombotic events. Platelet aggregation has been shown to be increased in patients with hypoxaemia and chronic airflow obstruction,2 with falls in platelet survival time, suggesting that hypoxia may increase platelet consumption. 3 Evidence from work with the isolated rat lung has suggested that platelets may potentiate the hypoxic vasoconstrictor response of the pulmonary circulation, and this could contribute to the development of pulmonary hypertension. 4 Larger platelets, as reflected by an increased mean platelet volume, appear to be haemostatically more active, with an increased aggregating ability.56 Studies in patients with myocardial infarction have shown platelet size to be increased, and this abnormal platelet function may lead to the development of coronary thrombosis.78 In patients with chronic lung disease larger, more active platelets could contribute to the development of pulmonary vascular changes.
In this study we Twelve patients with a Pao2 of 8 kPa (60 mm Hg) or less and nine patients with a Pao2 of more than 8 kPa (60 mm Hg) were treated in hospital with continuous supplemental oxygen via a face mask at 4 1 min-' for 24 hours. Arterial blood gas tensions, platelet count, and mean platelet volume were determined before and after the 24 hours of oxygen treatment. There were no alterations in the patients' medication during the study period.
Student's t test (two tailed), paired or unpaired as appropriate, was used for comparison of means for parametric data and the linear correlation coefficient (r) was calculated. Values of p below 0 05 were taken as significant. Table 1 shows the clinical details of the patients studied. The relationship between Pao2 and mean platelet volume for the patients is shown in figure 1, mean platelet volume increasing with the fall in Pao2 (r = -0 70; p < 0.001). The mean of the mean platelet volumes (9-41 (0 86) fl) for 20 patients with arterial hypoxaemia (Pao2 < 8 kPa (60 mm Hg)) was significantly greater than the mean (7 83 (0 60) fl) for 15 patients without hypoxaemia (p < 0-001). The mean for the hypoxic group was also greater than the mean for a group of 18 normal subjects without chronic airflow obstruction (8 21 (0 63) fl; p < 0 001). There was no significant correlation between mean platelet volume and Paco2. Table 2 compares the subjects who were treated with 24 hours of supplemental oxygen-12 hypoxaemic patients and 9 non-hypoxaemic patients. Mean Paco2 and packed cell volume were both greater in the hypoxaemic patients (p < 0-0 1), while mean Pao2 was significantly lower in the hypoxaemic group (7-27 (0 88) kPa (54 5 + 6-6 mm Hg)) than in the non- (fig 2) . The mean platelet count was lower for the 12 hypoxaemic patients than for the nine non-hypoxaemic subjects (p < 0-05; table 2). When the platelet counts were assessed for all 35 patients, however, there was a weak correlation with Pao2 (r = 0-41; p < 0-05) and with mean platelet volume (r = -046; p < 0-0 1). The 20 hypoxaemic patients had a lower mean platelet count (254 5 (91 9) x 109/1) than the 15 non-hypoxaemic patients (316.5 (90 6) x 109/l), but this difference was not significant. There was no change in the platelet counts after 24 hours ofoxygen treatment.
Results

Discussion
We have shown that platelet size as reflected by the mean platelet volume increases with increasing hypoxaemia in patients with chronic airflow obstruction. Larger platelets are thought to be more active6 and thus hypoxaemic patients will show increased platelet aggregation, leading to the release of more platelet vasoactive substances.'" This could contribute to the development of pulmonary vascular damage. 
